Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

180.410
-3.810-2.07%
Volume:210.87K
Turnover:38.69M
Market Cap:86.40B
PE:-23.41
High:187.000
Open:187.000
Low:180.330
Close:184.220
52wk High:216.734
52wk Low:88.830
Shares:478.91M
Float Shares:478.91M
Volume Ratio:1.31
T/O Rate:0.04%
Dividend:4.21
Dividend Rate:2.33%
EPS(TTM):-7.705
EPS(LYR):-7.705
ROE:-15.83%
ROA:7.26%
PB:4.05
PE(LYR):-23.41

Loading ...

CitiFirst CSL SFIs Dividend Estimated Amount-CTW

Reuters
·
Sep 08

CSL Says Vanguard Group Raises Stake

MT Newswires Live
·
Sep 04

Australian Shares Rise as Miners, Banks Gain on Lower Oil, Bond Yields

Reuters
·
Sep 03

Black Box Warning on CSL's Injectafer Unlikely to Change Much

Dow Jones
·
Sep 03

CSL Bulls Don't See Large Impact from U.S. Pricing Deals

Dow Jones
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

CSL's U.S. Agreements Remove Two Stock Overhangs

Dow Jones
·
Sep 01

ASX Preview: Australian Shares to Fall as Oil Surges on US-Iran Conflict; Ausgold Fiscal 2026 Loss Narrows

MT Newswires Live
·
Sep 01

CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing

MT Newswires Live
·
Sep 01

CSL Signs U.S. Government Agreements to Lower Drug Prices for Medicaid

Reuters
·
Sep 01

CSL Limited-Agreements with U.S. on Drug Prices and Manufacturing

THOMSON REUTERS
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

CSL Ltd: Agreements Support Lower Prices for CSL Therapies and Reflect CSL's $1.5 Billion Plan to Expand Its U.S. Manufacturing Capacity in Illinois

THOMSON REUTERS
·
Sep 01

CSL Enters Agreements with the U.S. Government to Lower Drug Prices and Support Investment in U.S. Manufacturing

THOMSON REUTERS
·
Sep 01

CSL : Agreements Provide CSL with Additional Certainty Regarding Exposure to U.S. Drug Pricing & Certain Section 232 Tariffs

THOMSON REUTERS
·
Sep 01

CSL : Entered into Onshoring Agreement with the U.S. Department of Commerce

THOMSON REUTERS
·
Sep 01

CSL : Project to Substantially Increase Co's Ability to Produce Immunoglobulins & Albumin for People with Rare Diseases & Serious Conditions

THOMSON REUTERS
·
Sep 01

CSL Ltd: Project is Expected to Create at Least 300 New Pharmaceutical Manufacturing Jobs and Approximately 800 Construction and Related Jobs

THOMSON REUTERS
·
Sep 01

CSL : Does not Anticipate Any Material Impact During Fiscal Year 2027

THOMSON REUTERS
·
Sep 01

CSL’s latest result suggests the worst may be over

Morning Star AU
·
Aug 31